Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival.

Wang XY, Penalva LO, Yuan H, Linnoila RI, Lu J, Okano H, Glazer RI.

Mol Cancer. 2010 Aug 21;9:221. doi: 10.1186/1476-4598-9-221.

2.

Musashi1 as a potential therapeutic target and diagnostic marker for lung cancer.

Wang XY, Yu H, Linnoila RI, Li L, Li D, Mo B, Okano H, Penalva LO, Glazer RI.

Oncotarget. 2013 May;4(5):739-50.

3.

RNA-binding protein Musashi1 modulates glioma cell growth through the post-transcriptional regulation of Notch and PI3 kinase/Akt signaling pathways.

Muto J, Imai T, Ogawa D, Nishimoto Y, Okada Y, Mabuchi Y, Kawase T, Iwanami A, Mischel PS, Saya H, Yoshida K, Matsuzaki Y, Okano H.

PLoS One. 2012;7(3):e33431. doi: 10.1371/journal.pone.0033431. Epub 2012 Mar 12. Erratum in: PLoS One. 2013;8(4). doi:10.1371/annotation/4c24fcf6-cf55-42f7-aa0d-3984048a2d16. PLoS One. 2012;7(7): doi/10.1371/annotation/ab178792-f423-4aaf-8c26-950a54b8fcca.

4.

Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.

Leung EL, Fiscus RR, Tung JW, Tin VP, Cheng LC, Sihoe AD, Fink LM, Ma Y, Wong MP.

PLoS One. 2010 Nov 19;5(11):e14062. doi: 10.1371/journal.pone.0014062.

6.

The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis.

Vo DT, Subramaniam D, Remke M, Burton TL, Uren PJ, Gelfond JA, de Sousa Abreu R, Burns SC, Qiao M, Suresh U, Korshunov A, Dubuc AM, Northcott PA, Smith AD, Pfister SM, Taylor MD, Janga SC, Anant S, Vogel C, Penalva LO.

Am J Pathol. 2012 Nov;181(5):1762-72. doi: 10.1016/j.ajpath.2012.07.031. Epub 2012 Sep 14.

7.

Musashi1 modulates mammary progenitor cell expansion through proliferin-mediated activation of the Wnt and Notch pathways.

Wang XY, Yin Y, Yuan H, Sakamaki T, Okano H, Glazer RI.

Mol Cell Biol. 2008 Jun;28(11):3589-99. doi: 10.1128/MCB.00040-08. Epub 2008 Mar 24.

8.

Krüppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cells.

Leng Z, Tao K, Xia Q, Tan J, Yue Z, Chen J, Xi H, Li J, Zheng H.

PLoS One. 2013;8(2):e56082. doi: 10.1371/journal.pone.0056082. Epub 2013 Feb 13.

9.

Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.

Calcagno AM, Salcido CD, Gillet JP, Wu CP, Fostel JM, Mumau MD, Gottesman MM, Varticovski L, Ambudkar SV.

J Natl Cancer Inst. 2010 Nov 3;102(21):1637-52. doi: 10.1093/jnci/djq361. Epub 2010 Oct 8.

10.

Numb regulates glioma stem cell fate and growth by altering epidermal growth factor receptor and Skp1-Cullin-F-box ubiquitin ligase activity.

Jiang X, Xing H, Kim TM, Jung Y, Huang W, Yang HW, Song S, Park PJ, Carroll RS, Johnson MD.

Stem Cells. 2012 Jul;30(7):1313-26. doi: 10.1002/stem.1120.

11.

Partial biological characterization of cancer stem-like cell line (WJ(2)) of human glioblastoma multiforme.

Wang J, Wang X, Jiang S, Lin P, Zhang J, Wu Y, Xiong Z, Ren JJ, Yang H.

Cell Mol Neurobiol. 2008 Nov;28(7):991-1003. doi: 10.1007/s10571-008-9273-2. Epub 2008 Mar 19.

PMID:
18350379
12.

Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.

Fang KM, Lin TC, Chan TC, Ma SZ, Tzou BC, Chang WR, Liu JJ, Chiou SH, Yang CS, Tzeng SF.

Glia. 2013 Sep;61(9):1402-17. doi: 10.1002/glia.22521. Epub 2013 Jul 6.

PMID:
23832679
13.

Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer.

Kagara N, Huynh KT, Kuo C, Okano H, Sim MS, Elashoff D, Chong K, Giuliano AE, Hoon DS.

Am J Pathol. 2012 Jul;181(1):257-67. doi: 10.1016/j.ajpath.2012.03.019. Epub 2012 May 21.

PMID:
22626806
14.

The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs.

Vo DT, Qiao M, Smith AD, Burns SC, Brenner AJ, Penalva LO.

RNA Biol. 2011 Sep-Oct;8(5):817-28. doi: 10.4161/rna.8.5.16041. Epub 2011 Sep 1.

PMID:
21881409
15.

Isolation and characterization of spheroid cells from human malignant melanoma cell line WM-266-4.

Na YR, Seok SH, Kim DJ, Han JH, Kim TH, Jung H, Lee BH, Park JH.

Tumour Biol. 2009;30(5-6):300-9. doi: 10.1159/000261073. Epub 2009 Nov 23.

PMID:
19940551
16.

Musashi1 regulates survival of hepatoma cell lines by activation of Wnt signalling pathway.

Chen K, Gao Q, Zhang W, Liu Z, Cai J, Liu Y, Xu J, Li J, Yang Y, Xu X.

Liver Int. 2015 Mar;35(3):986-98. doi: 10.1111/liv.12458. Epub 2014 Jan 29.

PMID:
24444033
17.

Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo.

deCarvalho AC, Nelson K, Lemke N, Lehman NL, Arbab AS, Kalkanis S, Mikkelsen T.

Stem Cells. 2010 Feb;28(2):181-90. doi: 10.1002/stem.264.

18.

Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.

Rennstam K, McMichael N, Berglund P, Honeth G, Hegardt C, Rydén L, Luts L, Bendahl PO, Hedenfalk I.

Breast Cancer Res Treat. 2010 Jul;122(2):315-24. doi: 10.1007/s10549-009-0568-x. Epub 2009 Oct 1.

PMID:
19795205
19.

Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.

Mitra A, Fillmore RA, Metge BJ, Rajesh M, Xi Y, King J, Ju J, Pannell L, Shevde LA, Samant RS.

Breast Cancer Res. 2008;10(2):R22. doi: 10.1186/bcr1874. Epub 2008 Mar 7.

20.

Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy.

Sanchez-Diaz PC, Burton TL, Burns SC, Hung JY, Penalva LO.

BMC Cancer. 2008 Sep 30;8:280. doi: 10.1186/1471-2407-8-280.

Supplemental Content

Support Center